Australia’s UDI rollout makes stock status a market-access decision
A cardiovascular manufacturer can have two batches of the same device awaiting supply in Australia and face different Unique Device Identification obligations for each. The device model and risk class matter, but they do not settle the position of every unit in inventory. Manufacturing, labelling and supply history can change the applicable date.
Australia’s mandatory UDI rollout began for Class III and Class IIb devices on 1 July 2026, subject to transition conditions. TGA’s current healthcare guidance explains why organisations receiving devices may still encounter stock without UDI during the transition. [1] For manufacturers and Australian sponsors, that is a supply-planning issue as well as a labelling project.
Establish which date applies to the stock
The current Medical Devices Regulations define a device’s “general start day” through several branches, including its class, qualifying EU certificate and stock history. The definition of EU certificate refers specifically to the MDD or IVDD; an EU certificate of any kind is not sufficient. [2]
Consider a hypothetical Class III cardiovascular device with no qualifying EU certificate in force on 30 June 2026. For stock manufactured and labelled before 1 July 2026, but not supplied in Australia before that date, the defined general start day is 1 July 2029. The otherwise-applicable date for that Class III branch is 1 July 2026. [2]
A model-level statement that “this product has until 2029” would therefore conceal an important distinction. Older stock and subsequent production can require different actions. A forecast based only on the product catalogue could promise supply without identifying which batch the promise depends on.
Stock location does not tell the whole story
TGA’s guidance connects the treatment of existing stock to whether it remains under sponsor control. Existing Class III and IIb devices in sponsor control must be relabelled by 1 July 2029. If returned to sponsor control after that date, they must be relabelled before resupply. [3]
That makes inventory movement relevant to the compliance decision. Consignment stock requires particular attention: TGA distinguishes stock accessible to hospital staff from stock held in a sponsor-controlled inventory location. Physical presence at a hospital does not, by itself, answer the question. [3]
The practical consequence is that a stock record needs to support more than a count of units. It should allow the sponsor to explain the batch’s status when deciding whether it can be supplied or resupplied.
Connect the label to the Australian data record
UDI implementation also includes AusUDID records. The regulations provide a 30-day period for including specified identifier information, beginning with first supply for use in Australia on or after the applicable general start day. [2] Direct marking has separate applicability and timing; it should not be folded into a single universal labelling deadline.
Zaliance recommends agreeing the manufacturer-to-sponsor handoff around the actual product and stock being supplied. The manufacturer’s identifier and packaging information, the sponsor’s inventory history and the Australian database record need to describe the same product configuration. That coordination is a practical recommendation, not an additional regulatory deadline.
A useful UDI implementation plan lets the team explain why a particular batch can be supplied and what remains to be done. Completing the artwork is one part of that answer.
References
[1] TGA. UDI requirements for medical devices: what healthcare organisations need to know. Published 31 August 2026; current implementation guidance.
https://www.tga.gov.au/products/medical-devices/labelling-and-advertising/unique-device-identification-udi-hub/udi-healthcare/udi-requirements-medical-devices-what-healthcare-organisations-need-know
[2] Therapeutic Goods (Medical Devices) Regulations 2002, compilation 72, 8 September 2026. Regulation 11.85; Schedule 1, clause 13C.2; Dictionary definitions of EU certificate, general start day and direct marking start day.
https://www.legislation.gov.au/F2002B00237/2026-09-08/2026-09-08/text/original/pdf
[3] TGA. Complying with the Unique Device Identification timeframes for medical devices, version 2.1, June 2026. Existing devices and sponsor control, PDF pp. 15–20.
https://www.tga.gov.au/sites/default/files/2025-03/complying-unique-device-identification-timeframes-medical-devices.pdf